Meso Numismatics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019
December 09, 2020 at 05:33 pm EST
Share
Meso Numismatics, Inc. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was USD 30,103 compared to USD 50,116 a year ago. Net loss was USD 2.509 million compared to USD 2.057 million a year ago. Basic loss per share from continuing operations was USD 0.47 compared to USD 0.5 a year ago.
Meso Numismatics, Inc. is a regenerative medicine company offering diverse products and services through its wholly owned subsidiary, Global Stem Cell Group Inc. It distributes stem cells and other regenerative based cell lines and equipment internationally and specializes in education and training physicians in regenerative medicine. It works with doctors and staff to provide products, solutions, equipment, services, and training to help them in the application of stem cell therapies. It is focused on the manufacturing and commercialization of viable cell therapy and immune support-related products. Its professional trademarked association, The International Society for Stem Cell Application (ISCCA), is a global network of medical professionals. Its flagship operation in Istanbul employs targeted combinations of exosomes, allogeneic human mesenchymal cells, and autologous bone marrow and adipose-derived stem cells to treat an array of diseases and debilitating medical conditions.
MESO NUMISMATICS, INC. 